The multicenter study coordinated by the University of Bergen, Norway, will last 4 years (2025-2028) and will be implemented in Ethiopia by the Armauer Hansen Research Institute (AHRI) and in Mozambique by the Manhiça Health Research Center (CISM), where it is intended to estimate the effectiveness of a low-cost point-of-care test, followed by a specific treatment for cryptosporidiosis with nitazoxanide (antiparasitic drug), on the duration of diarrhea in children who present at the
health units with diarrhea, which can reduce the average duration of diarrhea by at least two days.
Objective: To evaluate the clinical effectiveness of a low-cost point-of-care test, in conjunction with access to specific drug treatment, in reducing the duration of diarrhea due to cryptosporidiosis (infection with the protozoan Cryptosporidium spp, which is acquired by fecal-oral transmission).
Work packages
TEAM
PI
Physician
PARTNERS
